Browse by Aston Author

2018

Bailey, Clifford J. (2018). Glucose-lowering therapies in type 2 diabetes: Opportunities and challenges for peptides. Peptides, 100 , pp. 9-17.

2017

Lascar, Nadia; Brown, James; Pattison, Helen; Barnett, Anthony H.; Bailey, Clifford J. and Bellary, Srikanth (2017). Type 2 diabetes in adolescents and young adults. The Lancet Diabetes and Endocrinology, in pre ,

Bailey, Clifford J. (2017). Metformin:historical overview. Diabetologia, 60 (9), 1566–1576.

2016

Bailey, Clifford J. (2016). Under-treatment of type 2 diabetes:causes and outcomes of clinical inertia. International Journal of Clinical Practice, 70 (12), pp. 988-995.

McCreight, Laura J.; Bailey, Clifford J. and Pearson, Ewan R. (2016). Metformin and the gastrointestinal tract. Diabetologia, 59 (3), pp. 426-435.

Pararasa, Chathyan; Ikwuobe, John; Shigdar, Shahjahan; Boukouvalas, Alexis; Nabney, Ian T.; Brown, James E.; Devitt, Andrew; Bailey, Clifford J.; Bennett, Stuart J. and Griffiths, Helen R. (2016). Age-associated changes in long-chain fatty acid profile during healthy aging promote pro-inflammatory monocyte polarization via PPARγ. Aging Cell, 15 (1), pp. 128-139.

2015

Pararasa, Chathyan; Bailey, Clifford J. and Griffiths, Helen R. (2015). Ageing, adipose tissue, fatty acids and inflammation. Biogerontology, 16 (2), pp. 235-248.

Qureshi, Khalid M.; Lee, Jou; Paget, Michelle B.; Bailey, Clifford J.; Curnow, S. John; Murray, Hilary E. and Downing, Richard (2015). Low gravity rotational culture and the integration of immunomodulatory stem cells reduce human islet allo-reactivity. Clinical Transplantation, 29 (1), pp. 90-98.

Day, Caroline and Bailey, Clifford J. (2015). Cardiovascular outcome trials in type 2 diabetes – 2015. Diabesity in practice, 4 (4), pp. 131-133.

Day, Caroline and Bailey, Clifford J. (2015). Pharmacotherapies to manage diabesity:an update. Diabesity in practice, 4 (1), pp. 14-23.

2014

Home, Philip; Riddle, Matthew; Cefalu, William T.; Bailey, Clifford J.; Bretzel, Reinhard G.; del Prato, Stefano; Leroith, Derek; Schernthaner, Guntram; van Gaal, Luc and Raz, Itamar (2014). Response to comment on Home et al. Insulin therapy in people with type 2 diabetes:opportunities and challenges? Diabetes care 2014;37:1499-1508. Diabetes Care, 37 (11),

Bailey, Clifford J.; Azar, S.T.; Blonde, Lawrence; Dicker, D.; Puig-domingo, M; Eliaschewitz, F.G.; Nikonova, E.; Roussel, R.; Sakaguchi, K; Sauque-Reyna, L and Nauck, M. (2014). Relationship between changes in postprandial glucagon, patient characteristics, and response to lixisenatide as add-on to oral antidiabetics. Diabetologia, 57 (Suppl.), S344.

Fouqueray, Pascale; Pirags, Valdis; Diamant, Michaela; Schernthaner, Guntram; Lebovitz, Harold E.; Inzucchi, Silvio E. and Bailey, Clifford J. (2014). The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with sitagliptin monotherapy. Diabetes Care, 37 (7), pp. 1924-1930.

Home, Philip; Riddle, Matthew; Cefalu, William T.; Bailey, Clifford J.; Bretzel, Reinhard G.; del Prato, Stefano; Leroith, Derek; Schernthaner, Guntram; van Gaal, Luc and Raz, Itamar (2014). Insulin therapy in people with type 2 diabetes:opportunities and challenges? Diabetes Care, 37 (6), pp. 1499-1508.

Rana, Karan S.; Arif, Muhammad; Hill, Eric J.; Aldred, Sarah; Nagel, David A.; Nevill, Alan; Randeva, Harpal S.; Bailey, Clifford J.; Bellary, Srikanth and Brown, James E. (2014). Plasma irisin levels predict telomere length in healthy adults. Age, 36 (2), pp. 995-1001.

Al-Khattawi, Ali; Iyrie, Affiong; Dennison, Tom; Dahmash, Eman; Bailey, Clifford J.; Smith, Julian; Rue, Peter and Mohammed, Afzal R. (2014). Systematic screening of compressed ODT excipients:cellulosic versus non-cellulosic. Current Drug Delivery, 11 (4), pp. 486-500.

2013

Paget, Michelle B.; Murray, Hilary E.; Bailey, Clifford J. and Downing, Richard (2013). Pre-transplant signal induction for vascularisation in human islets. Diabetes and Vascular Disease Research, 10 (6), pp. 536-545.

Tahrani, Abd A.; Barnett, Anthony H. and Bailey, Clifford J. (2013). SGLT inhibitors in management of diabetes. The Lancet Diabetes and Endocrinology, 1 (2), pp. 140-151.

Bailey, Clifford J.; Aschner, Pablo; del Prato, James; LaSalle, James; Ji, Linong and Matthaei, Stephan (2013). Individualized glycaemic targets and pharmacotherapy in type 2 diabetes. Diabetes and Vascular Disease Research, 10 (5), pp. 397-409.

Bailey, Clifford J. (2013). Interpreting adverse signals in diabetes drug development programs. Diabetes Care, 36 (7), pp. 2098-2106.

Bailey, Clifford J. (2013). Treatment with metformin. IN: The metabolic syndrome. Beck-Nielsen, Henning (ed.) Vienna (AT): Springer.

Fouqueray, Pascale; Pirags, Valdis; Inzucchi, Silvio E.; Bailey, Clifford J.; Schernthaner, Guntram; Diamant, Michaela and Lebovitz, Harold E. (2013). The efficacy and safety of imeglimin as add-on therapy in patientswith type 2 diabetes inadequately controlled with metformin monotherapy. Diabetes Care, 36 (3), pp. 565-568.

2012

Gao, Dan; Pararasa, Chathyan; Dunston, Christopher R; Bailey, Clifford J. and Griffiths, Helen R. (2012). Palmitate promotes monocyte atherogenicity via de novo ceramide synthesis. Free Radical Biology and Medicine, 53 (4), 796–806.

Bailey, Clifford J. (2012). Diabetes : insulin plus metformin for T2DM-are there benefits? Nature Reviews Endocrinology, 8 (8), pp. 449-450.

Bailey, Clifford J.; Day, Caroline; Campbell, Ian W. and Schindler, Christoph (2012). Glycaemic control and cardiovascular outcome trials in type 2 diabetes. British Journal of Diabetes and Vascular Disease, 12 (4), pp. 161-164.

Tahrani, Abd A.; Bailey, Clifford J. and Barnett, Anthony H. (2012). Insulin degludec:a new ultra-longacting insulin. The Lancet, 379 (9825), pp. 1465-1467.

Day, Caroline and Bailey, Clifford J. (2012). The hypocaloric diet in type 2 diabetes - déjà vu. British Journal of Diabetes and Vascular Disease, 12 (1), pp. 48-51.

2011

Day, Caroline and Bailey, Clifford J. (2011). Metformin. IN: xPharm. Enna, S.J. and Bylund, David B. (eds) Elsevier.

Day, Caroline and Bailey, Clifford J. (2011). Pioglitazone. IN: xPharm. Enna, S.J. and Bylund, David B. (eds) Elsevier.

Day, Caroline and Bailey, Clifford J. (2011). Obesity in the pathogenesis of type 2 diabetes. British Journal of Diabetes and Vascular Disease, 11 (2), pp. 55-61.

Day, Caroline and Bailey, Clifford J. (2011). Biguanides. IN: xPharm. Enna, S.J. and Bylund, David B. (eds) Elsevier.

Day, Caroline and Bailey, Clifford J. (2011). Ciglitazone. IN: xPharm. Enna, S.J. and Bylund, David B. (eds) Elsevier.

Day, Caroline and Bailey, Clifford J. (2011). Rosiglitazone. IN: xPharm. Enna, S.J. and Bylund, David B. (eds) Elsevier.

Bailey, Clifford J. (2011). Thiazolidinediones. IN: xPharm. Enna, S.J. and Bylund, David B. (eds) Elsevier.

Day, Caroline and Bailey, Clifford J. (2011). Troglitazone. IN: xPharm. Elsevier.

Qureshi, Khalid M.; Oliver, Robert J.; Paget, Michelle B; Murray, Hilary E; Bailey, Clifford J. and Downing, Richard (2011). Human amniotic epithelial cells induce localized cell-mediated immune privilege in vitro:implications for pancreatic islet transplantation. Cell Transplantation, 20 (4), pp. 523-534.

2010

Bailey, Clifford J.; Green, Brian D. and Flatt, Peter R. (2010). Fixed-dose combination therapy for type 2 diabetes:sitagliptin plus pioglitazone. Expert Opinion on Investigational Drugs: authoritative analysis of r and d trends, 19 (8), pp. 1017-1025.

Bailey, Clifford J. (2010). Future drug treatments for type 2 diabetes. IN: Textbook of diabetes. Holt, Richard I.G.; Cockram, Clive S.; Flyvbjerg, Allan and Goldstein, Barry J. (eds) Wiley-Blackwell.

Bailey, Clifford J. and Krentz, Andrew J. (2010). Oral antidiabetic agents. IN: Textbook of diabetes. Holt, Richard I.G.; Cockram, Clive S.; Flyvbjerg, Allan and Goldstein, Barry J. (eds) Wiley-Blackwell.

Bailey, Clifford J.; Gross, Jorge L.; Pieters, Anne; Bastien, Arnaud and List, James F. (2010). Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin:a randomised, double-blind, placebo-controlled trial. The Lancet, 375 (9733), pp. 2223-2233.

Bailey, Clifford J. and Barnett, Anthony H. (2010). Inhaled insulin:new formulation, new trial. The Lancet, 375 (9733), pp. 2199-201.

Bergenstal, Richard M.; Bailey, Clifford J. and Kendall, David M. (2010). Type 2 diabetes:assessing the relative risks and benefits of glucose-lowering medications. American Journal of Medicine, 123 (4), 374.e9-374.e18.

Bailey, Clifford J. and Day, Caroline (2010). Hypoglycaemia:a limiting factor. British Journal of Diabetes and Vascular Disease, 10 (1), pp. 2-4.

2009

Gao, Dan; Bailey, Clifford J. and Griffiths, Helen R. (2009). Metabolic memory effect of the saturated fatty acid, palmitate, in monocytes. Biochemical and Biophysical Research Communications, 388 (2), pp. 278-282.

Tan, Bee K.; Chen, Jing; Adya, Raghu; Ramanjaneya, Manjunath; Menon, Vinod; Bailey, Clifford J.; Brown, James; Lehnert, Hendrik and Randeva, Harpal S. (2009). In vivo and ex vivo regulation of visfatin production by leptin in human and murine adipose tissue: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Endocrinology, 150 (8), pp. 3530-3539.

Day, Caroline and Bailey, Clifford J. (2009). HbA1c - changing units. British Journal of Diabetes and Vascular Disease, 9 (3), pp. 134-136.

Flatt, Peter R.; Day, Caroline and Bailey, Clifford J. (2009). Review: bariatric surgery:to treat diabesity. British Journal of Diabetes and Vascular Disease, 9 (3), pp. 103-107.

2008

Krentz, Andrew J.; Patel, Mayank B. and Bailey, Clifford J. (2008). New drugs for type 2 diabetes mellitus:what is their place in therapy? Drugs, 68 (15), pp. 2131-2162.

Bailey, Clifford J. (2008). Metformin:effects on micro and macrovascular complications in type 2 diabetes. Cardiovascular Drugs and Therapy, 22 (3), pp. 215-224.

Bailey, Clifford J.; Barnett, Anthony H. and Petrie, John R. (2008). Value of glycaemic control in diabetes. The Lancet, 371 (9607), p. 116.

2007

Bailey, Clifford J. and Barnett, Anthony H. (2007). Why is Exubera being withdrawn? BMJ, 335 (7630), p. 1156.

Bailey, Clifford J.; Barnett, Anthony H. and Day, Caroline (2007). Exubera expires. British Journal of Diabetes and Vascular Disease, 7 (6), pp. 255-256.

Day, Caroline and Bailey, Clifford J. (2007). Glycaemic control IS important. British Journal of Diabetes and Vascular Disease, 7 (5), pp. 197-198.

Bailey, Clifford J. (2007). Learning from tesaglitazar. Diabetes and Vascular Disease Research, 4 (3), pp. 161-162.

Gao, Dan; Griffiths, Helen R. and Bailey, Clifford J. (2007). Palmitate induces insulin resistance in monocytes and increases expression of the integrin CD11b. IN: Scientific Meeting of the Nutrition Society. 2007-07-01. (Unpublished)

O'Harte, Finbarr P.M.; Hunter, Kerry; Gault, Victor A.; Irwin, Nigel; Green, Brian D.; Greer, Brett; Harriott, Patrick; Bailey, Clifford J. and Flatt, Peter R. (2007). Antagonistic effects of two novel GIP analogs, (Hyp3)GIP and (Hyp3)GIPLys16PAL, on the biological actions of GIP and longer-term effects in diabetic ob/ob mice. American Journal of Physiology, 292 (6), E1674-E1682.

2006

Bailey, Clifford J.; Day, Caroline and Campbell, Ian W. (2006). A consensus algorithm for treating hyperglycaemia in type 2 diabetes. British Journal of Diabetes and Vascular Disease, 6 (4), pp. 147-148.

1973

Bailey, Clifford J. (1973). Studies on the influence of sex hormones on glucose tolerance and insulin secretion in the rat. PHD thesis, Aston University.